Neil O. Fishman

Infectious Diseases · 2007–2016

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Neil O. Fishman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. B. Spellberg
  2. H. Boucher
  3. Susan Michie
  4. T. Dellit

Who trusts Neil O. Fishman overall

  1. C. Manyi-Loh
  2. L. Pollack

Papers from Neil O. Fishman's perspective

Ordered by how strongly the researchers Neil O. Fishman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Summary of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
  2. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  3. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. (Clinical Infectious Diseases)
  4. The impact of antimicrobial resistance on health and economic outcomes. (Clinical Infectious Diseases)
  5. Antimicrobial Prophylaxis for Surgery: An Advisory Statement From the National Surgical Infection Prevention Project
  6. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (Clinical Infectious Diseases)
  7. SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus (Infection Control & Hospital Epidemiology)
  8. Going from evidence to recommendations (British medical journal)
  9. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
  10. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. (Clinical Infectious Diseases)

Their papers